Updates from the FDA on GLP-1 agonists.
Aschenbrenner DSDiane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She also coordinates Drug Watch: diane.aschenbrenner@gmail.com. Pub Type(s)
Journal Article
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.